[Structure-metabolism-activity relationship in 17 alpha-CH2X-substituted estra-1,3,5,(10)-trienen].
D000284:Administration, Oral; D000818:Animals; D001386:Azides / Q000494:pharmacology; D003864:Depression, Chemical; D004958:Estradiol / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D007279:Injections, Subcutaneous; D008099:Liver / Q000378:metabolism; D008297:Male; D008738:Methyl Ethers / Q000494:pharmacology; D051379:Mice; D009570:Nitriles / Q000494:pharmacology; D010477:Perfusion; D010902:Pituitary Gland / Q000378:metabolism; D011374:Progesterone / Q000096:biosynthesis; D051381:Rats; D011956:Receptors, Cell Surface; D013329:Structure-Activity Relationship; D014599:Uterus / Q000187:drug effects / Q000378:metabolism
D001386:Azides; D004967:Estrogens; D008738:Methyl Ethers; D009570:Nitriles; D011956:Receptors, Cell Surface; D011374:Progesterone; D004958:Estradiol
Struktur-Stoffwechsel-Wirkungsbeziehungen bei 17alpha-CH2X-substituierten Ostra-1.3.5(10)-trienen